`
`
`
`
`The Medac Pharma first RA Advisory Council took place on September 29, 2012, at the Hilton O'Hare Hotel,
`Chicago, IL. The meeting was attended by 12 US rheumatology leaders (see attached participant list. Yusuf Yazici
`MD served as program chair. Presentations were made by Dr. Yazici, Ulf Muller-Ladner MD and members of
`medac GmbH and Medac Pharma.
`
`Meeting objectives:
`Introduce Medac Pharma and Metoject®
`
` Gain feedback on Metoject’s clinical profile
`
`Identify the key scientific messages that support Metoject
` Understand the role of Metoject in the treatment of RA
` Gain input into Medac Pharma activities to support the rheumatology community
`
`
`
`
`
`
`
`
`1
`
`Redacted
`
`Medac Exhibit 2008
`Koios v. Medac
`IPR2016-01370
`Page 00001
`
`
`
`
`
`
`
`2
`
`Page 00002
`
`Redacted
`
`Page 00002
`
`
`
`
`
`
`
`3
`
`Page 00003
`
`Redacted
`
`Page 00003
`
`
`
`
`Agenda
`September 29, 2012
`
`
`
`
`
`ADDENDUM
`
`
`
`Time
`
`
`
`
`
`Presentation
`
`
`
`8:00-8: 15 am
`
`
`
`
`8:15-8:30 am
`
`
`
`
`
`
`
`8:30-9:45 am
`
`9:45-10:00 am
`
`10:00-11:30 am
`
`
`
`
`
`
`
`11:30-12:00 pm
`
`
`
`
`12:00-12:45
`
`12:45-1:30 pm
`
`1:30-2:30pm
`
`2:30-3:00 pm
`
`3:00-3:15 pm
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Speaker
`
`Yusuf Yazici, MD
`NYU Langone Medical Center
`
`Ulrich Kosciessa
`Managing Director
`medac, GmbH
`
`Yusuf Yazici, MD
`
`Ulf Muller-Ladner, MD
`Justus-Liebig-University Giessen
`Kerckhoff Clinic Bad Nauheim
`
`Terri Shoemaker
`CEO, Medac Pharma
`
`Welcome and Introductions
`
`
`
`
`
`Introduction to Medac Pharma
`
`
`
`
`
`
`
`
`
`
`
`RA Treatment Dynamics
`
`BREAK
`
`Metoject® Review
`
`
`
`
`
`
`
`
`
`
`
`Competitive Landscape
`
`
`
`
`
`LUNCH
`
`
`
`
`
`
`
`
`
`
`Scientific Message Platform Review
`
`Carol Gorman, MS
`
`Launching Metoject: Considerations
`
`All
`
`Medac Pharma Rheumatology Activities
`
`All
`
`Closing Remarks
`
`
`
`
`
`
`
`Terri Shoemaker
`
`
`
`
`
`
`
`4
`
`Page 00004
`
`
`
`
`PARTICIPANT LIST
`
`
`Michael Schiff, MD
`Greenwood, CO
`
`Sergio Schwartzman, MD
`Hospital for Special Surgery
`New York, NY
`
`Alvin Wells, MD, PhD
`Rheumatology and Immunotherapy Center
`Grayslake, IL
`
`Yusuf Yazici, MD
`New York University School of Medicine
`New York, NY
`
`medac pharma, Inc - Attendees
`
`Terri Shoemaker, CEO
`Leawood, KS
`
`
`Gary Grossman, VP of Sales
`Los Angeles, CA
`
`medac GmbH - Attendees
`
`Dr. Ulrich Kosciessa, Managing Director
`Wedel, Germany
`
`Henrik Fenger, Director of Corporate Development
`Wedel, Germany
`
`Consultants
`
`Colleen Doyle
`Carol Gorman, MS
`Cari Weisberg
`Tanya Zuckerman
`
`
`
`5
`
`
`
`ADDENDUM
`
`
`Martin Bergman, MD
`Ridley Park, PA
`
`Louis Bridges, MD, PhD
`University of Alabama
`Birmingham, AL
`
`Jeffrey Curtis, MD, MS, MPH
`University of Alabama at Birmingham
`Birmingham, AL
`
`Allan Gibofsky, MD, JD
`Hospital for Special Surgery
`New York, NY
`
`John Goldman, MD
`Atlanta, GA
`
`Jonathan Kay, MD
`University of Massachusetts Medical
`School Rheumatology Center
`Worcester, MA
`
`Gail Kerr, MD, FRCP
`Howard University Hospital
`Washington, DC
`
`Carlos Lozada, MD
`University of Miami
`Miami, FL
`
`Prof. Ulf Muller-Ladner, MD
`Justus-Liebig University Giessen
`Kerckhoff Clinic Bad Nauheim
`
`Ted Pincus, MD
`New York University School of Medicine
`and NYU Hospital for Joint Disease
`New York, NY
`
`
`
`
`
`
`
`Page 00005